Interchangeable Biologics Clarity Act
This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2022-05-25 | IntroReferral | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710) | Senate |
| 2022-05-25 | IntroReferral | Introduced in Senate | Library of Congress |